120 related articles for article (PubMed ID: 19027794)
1. Notch ligand Delta-like4 inhibits the development of murine experimental allergic conjunctivitis.
Fukushima A; Sumi T; Ishida W; Ojima A; Kajisako M; Koyanagi A; Koyama N; Yagita H
Immunol Lett; 2008 Dec; 121(2):140-7. PubMed ID: 19027794
[TBL] [Abstract][Full Text] [Related]
2. Roles of OX40 in the development of murine experimental allergic conjunctivitis: exacerbation and attenuation by stimulation and blocking of OX40.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Yagita H; Ueno H
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):657-63. PubMed ID: 16431965
[TBL] [Abstract][Full Text] [Related]
3. CD27 and CD70 do not play a critical role in the development of experimental allergic conjunctivitis in mice.
Sumi T; Ishida W; Ojima A; Kajisako M; Sakanishi T; Yagita H; Fukushima A
Immunol Lett; 2008 Aug; 119(1-2):91-6. PubMed ID: 18579220
[TBL] [Abstract][Full Text] [Related]
4. Participation of CD11b and F4/80 molecules in the conjunctival eosinophilia of experimental allergic conjunctivitis.
Fukushima A; Ishida W; Ojima A; Kajisako M; Sumi T; Yamada J; Tsuru E; Miyazaki J; Tominaga A; Yagita H
Int Arch Allergy Immunol; 2010; 151(2):129-36. PubMed ID: 19752566
[TBL] [Abstract][Full Text] [Related]
5. Endogenous IL-17 does not play a significant role in the development of experimental murine allergic conjunctivitis.
Fukushima A; Sumi T; Ishida W; Yamada J; Iwakura Y; Ueno H
Int Arch Allergy Immunol; 2008; 147(3):206-12. PubMed ID: 18594150
[TBL] [Abstract][Full Text] [Related]
6. Roles of galectin-9 in the development of experimental allergic conjunctivitis in mice.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Okumura K; Akiba H; Yagita H; Ueno H
Int Arch Allergy Immunol; 2008; 146(1):36-43. PubMed ID: 18087160
[TBL] [Abstract][Full Text] [Related]
7. Role of VLA-4 in the development of allergic conjunctivitis in mice.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ueno H
Mol Vis; 2006 Apr; 12():310-7. PubMed ID: 16617298
[TBL] [Abstract][Full Text] [Related]
8. The immunization protocol determines whether endogenous interferon-gamma suppresses the infiltration of eosinophils into the conjunctiva.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Ozaki A; Ueno H
Immunol Lett; 2005 Sep; 100(2):189-94. PubMed ID: 15919119
[TBL] [Abstract][Full Text] [Related]
9. Endogenous interleukin-10 produced by antigen-irrelevant cells promotes the development of experimental murine allergic conjunctivitis.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Ueno H
Int Arch Allergy Immunol; 2007; 144(1):79-84. PubMed ID: 17505142
[TBL] [Abstract][Full Text] [Related]
10. Activation of tumour-necrosis factor-related apoptosis-inducing ligand receptor enhances the severity of murine allergic conjunctivitis.
Sumi T; Ishida W; Okumura K; Yagita H; Fukushima A
Br J Ophthalmol; 2009 Jan; 93(1):110-5. PubMed ID: 18782797
[TBL] [Abstract][Full Text] [Related]
11. Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice.
Sumi T; Fukushima A; Nishino K; Fukuda K; Kumagai N; Nishida T; Ueno H
Cell Biol Int; 2009 Apr; 33(4):534-41. PubMed ID: 19230848
[TBL] [Abstract][Full Text] [Related]
12. Involvement of programmed death-ligand 2 (PD-L2) in the development of experimental allergic conjunctivitis in mice.
Fukushima A; Yamaguchi T; Azuma M; Yagita H; Ueno H
Br J Ophthalmol; 2006 Aug; 90(8):1040-5. PubMed ID: 16613922
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells participate in 4-1BB-mediated suppression of experimental allergic conjunctivitis.
Sumi T; Ishida W; Mittler RS; Yagita H; Taguchi O; Fukushima A
Int Arch Allergy Immunol; 2009; 148(4):305-10. PubMed ID: 19001790
[TBL] [Abstract][Full Text] [Related]
14. Systemic overexpression of IFN-gamma and IL-5 exacerbates early phase reaction and conjunctival eosinophilia, respectively, in experimental allergic conjunctivitis.
Ishida W; Tsuru E; Tominaga A; Miyazaki JI; Higuchi T; Sakamoto S; Fukushima A
Br J Ophthalmol; 2009 Dec; 93(12):1680-5. PubMed ID: 19692377
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 10 and transforming growth factor beta contribute to the development of experimentally induced allergic conjunctivitis in mice during the effector phase.
Fukushima A; Sumi T; Fukuda K; Kumagai N; Nishida T; Yagita H; Ueno H
Br J Ophthalmol; 2006 Dec; 90(12):1535-41. PubMed ID: 16914468
[TBL] [Abstract][Full Text] [Related]
16. CD8+ T cells play disparate roles in the induction and the effector phases of murine experimental allergic conjunctivitis.
Fukushima A; Yamaguchi T; Fukuda K; Sumi T; Kumagai N; Nishida T; Imai S; Ueno H
Microbiol Immunol; 2006; 50(9):719-28. PubMed ID: 16985294
[TBL] [Abstract][Full Text] [Related]
17. Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: comparison of Balb/c and C57BL/6 mice.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Taniguchi T; Liu FT; Ueno H
Exp Eye Res; 2006 Feb; 82(2):210-8. PubMed ID: 16102751
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions.
Fukushima A; Yamaguchi T; Ishida W; Fukata K; Liu FT; Ueno H
Clin Exp Ophthalmol; 2006; 34(4):347-53. PubMed ID: 16764655
[TBL] [Abstract][Full Text] [Related]
19. Fyn regulates eosinophil infiltration into the conjunctiva by downregulating the Th2 response.
Fukushima A; Yamaguchi T; Ozaki A; Taniguchi T; Udaka K; Ueno H
Graefes Arch Clin Exp Ophthalmol; 2005 Oct; 243(10):1043-9. PubMed ID: 15838661
[TBL] [Abstract][Full Text] [Related]
20. Modulation of murine experimental allergic conjunctivitis by treatment with alpha-galactosylceramide.
Fukushima A; Sumi T; Fukuda K; Yamaguchi T; Kumagai N; Nishida T; Ueno H
Immunol Lett; 2006 Sep; 107(1):32-40. PubMed ID: 16930723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
